Bruce G. Allen Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Bruce G. Allen Investments's GILD Position: Q2 2026 in Review
Bruce G. Allen Investments reduced its Gilead Sciences (GILD) stake by 0.61% in Q2 2026, selling an estimated $791 and leaving 983 shares worth $124K. The position accounts for 0.08% of the portfolio, ranked #131.
Bruce G. Allen Investments first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $178K in Q1 2025. 1,031 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Bruce G. Allen Investments held 983 shares of Gilead Sciences worth $124K as of Q2 2026.
- Bruce G. Allen Investments sold 6 Gilead Sciences shares in Q2 2026, an estimated $791.
- Gilead Sciences made up 0.08% of Bruce G. Allen Investments's portfolio in Q2 2026, its #131 holding.
- Bruce G. Allen Investments first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
- Bruce G. Allen Investments's Gilead Sciences position peaked at $178K in Q1 2025.
- 1,031 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.